0.00Open0.00Pre Close0 Volume0 Open Interest28.50Strike Price0.00Turnover0.00%IV63.51%PremiumNov 8, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma51.26Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Teva Pharmaceutical Industries Stock Discussion
They make the ADD meds, which is in short supply, still.
On Monday, former President Donald Trump surpassed Vice President Kamala Harris in polling support for the first time since August.
This follows betting markets indicating a higher probability of a Trump victory in the upcoming 🗳 election.
The U.S. stock market is witnes...
The U.S. stock market is witnessing a revival of the "Trump Trade." Shares in Trump's social media venture, $Trump Media & Technology (DJT.US)$ , have soared more than 220% since October, while $Phunware (PHUN.US)$ has jumpe...
Jefferies analysts cited 10 possible policies that Tr...
Polls Show Harris Leading Trump
According to the latest polling by The New York Times and Siena College, Harris leads Trump by fo...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX – Research Report), Eli Lilly & Co (LLY – Research Report) and Teva Pharmaceutical (TEVA – Research Report) with bullish sentiments.
Immuneering (IMRX)
In a report issued on A...
$Air Products & Chemicals (APD.US)$ : “You really don’t want to be in Air Products, you want to be in Linde. Linde’s a much better run company, and that’s why Air Products isn’t doing as well , and Linde’s doing spectacularly.”
$Sarepta Therapeutics (SRPT.US)$ : “I think Sarepta is a speculative situation where they have great science. ...
No comment yet